Imperial College London
Alternate

Professor Sir Roy Anderson FRS, FMedSci

Faculty of Medicine, School of Public Health

Professor in Infectious Disease Epidemiology
 
 
 
//

Contact

 

roy.anderson Website

 
 
//

Assistant

 

Mrs Clare Mylchreest +44 (0)7766 331 301

 
//

Location

 

LG35Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Kura:2021:trstmh/traa202,
author = {Kura, K and Ayabina, D and Toor, J and Hollingsworth, TD and Anderson, RM},
doi = {trstmh/traa202},
journal = {Transactions of the Royal Society of Tropical Medicine and Hygiene},
pages = {236--244},
title = {Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies.},
url = {http://dx.doi.org/10.1093/trstmh/traa202},
volume = {115},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BACKGROUND: The 2030 goal for schistosomiasis is elimination as a public health problem (EPHP), with mass drug administration (MDA) of praziquantel to school-age children (SAC) as a central pillar of the strategy. However, due to coronavirus disease 2019, many mass treatment campaigns for schistosomiasis have been halted, with uncertain implications for the programmes. METHODS: We use mathematical modelling to explore how postponement of MDA and various mitigation strategies affect achievement of the EPHP goal for Schistosoma mansoni and S. haematobium. RESULTS: For both S. mansoni and S. haematobium in moderate- and some high-prevalence settings, the disruption may delay the goal by up to 2 y. In some high-prevalence settings, EPHP is not achievable with current strategies and so the disruption will not impact this. Here, increasing SAC coverage and treating adults can achieve the goal. The impact of MDA disruption and the appropriate mitigation strategy varies according to the baseline prevalence prior to treatment, the burden of infection in adults and the stage of the programme. CONCLUSIONS: Schistosomiasis MDA programmes in medium- and high-prevalence areas should restart as soon as is feasible and mitigation strategies may be required in some settings.
AU  - Kura,K
AU  - Ayabina,D
AU  - Toor,J
AU  - Hollingsworth,TD
AU  - Anderson,RM
DO  - trstmh/traa202
EP  - 244
PY  - 2021///
SN  - 0035-9203
SP  - 236
TI  - Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies.
T2  - Transactions of the Royal Society of Tropical Medicine and Hygiene
UR  - http://dx.doi.org/10.1093/trstmh/traa202
UR  - https://www.ncbi.nlm.nih.gov/pubmed/33515038
UR  - http://hdl.handle.net/10044/1/88101
VL  - 115
ER  -
Download